Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $7.14 and last traded at $7.6350, with a volume of 292131 shares trading hands. The stock had previously closed at $8.05.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on LMRI shares. Weiss Ratings started coverage on shares of Lumexa Imaging in a report on Wednesday. They set a “sell (e-)” rating on the stock. Raymond James Financial raised shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective on the stock in a report on Monday, February 9th. Finally, Barclays cut their price objective on shares of Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Lumexa Imaging presently has a consensus rating of “Moderate Buy” and an average target price of $19.00.
Check Out Our Latest Stock Analysis on Lumexa Imaging
Lumexa Imaging Stock Performance
Hedge Funds Weigh In On Lumexa Imaging
A number of hedge funds and other institutional investors have recently made changes to their positions in LMRI. Assetmark Inc. purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $36,000. Geode Capital Management LLC purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $1,548,000. Seven Grand Managers LLC purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $11,942,000. Goldman Sachs Group Inc. purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $18,870,000. Finally, TD Asset Management Inc purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $1,264,000.
Lumexa Imaging Company Profile
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
Read More
- Five stocks we like better than Lumexa Imaging
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
- MarketBeat Week in Review – 05/11 – 05/15
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
